Pages that link to "Q39576406"
Jump to navigation
Jump to search
The following pages link to Treatment of Paget's Disease with the Calcitonins* (Q39576406):
Displaying 13 items.
- A double-blind controlled trial of salmon calcitonin in pain due to malignancy (Q34056310) (← links)
- Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance (Q40292517) (← links)
- Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone (Q44313222) (← links)
- Hypocalcemic actions of amylin amide in humans (Q46082226) (← links)
- Haemophilus influenzae, ampicillin sensitivity, and inoculum size (Q47292001) (← links)
- Paget's disease of bone. An update on management. (Q54446376) (← links)
- Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation (Q70483492) (← links)
- 25 years of salmon calcitonin: from synthesis to therapeutic use (Q70952129) (← links)
- Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin (Q71359629) (← links)
- A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss (Q72198398) (← links)
- Spinal-cord syndrome due to non-compressive Paget's disease of bone: a spinal-artery steal phenomenon reversible with calcitonin (Q72425659) (← links)
- Spinal-artery "steal" in Paget's disease of bone (Q72429162) (← links)
- Actions of calcitonin and mithramycin (Q72867394) (← links)